Vaccine Adjuvants Market Projected To Raise At USD 4.86 Billion By 2030


 San Francisco, 31 December 2024: The Report Vaccine Adjuvants Market Size, Share & Trends Analysis Report By Type (Pathogen, Adjuvant Emulsion, Particulate), By Administration (Oral, Intradermal, Intranasal, Intramuscular), By Application, By Region, And Segment Forecasts, 2025 - 2030

The global vaccine adjuvants market is expected to reach USD 4.86 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 4.32% from 2025 to 2030. The significance of adjuvant research in the development of vaccines has increased gradually due to inadequate immunogenicity of innovative vaccine antigens. In addition, the growing focus on long-lasting immunization effect against existing and emerging diseases is expected to boost the demand for vaccine adjuvants.

Furthermore, rising prevalence of cervical cancer is anticipated to boost the market. According to NCBI, around 15,000 females die every year due to cervical cancer. There are certain companies developing vaccine adjuvants for this type of cancer in order to enhance the efficacy, such as AS04 adjuvant-adsorbed (human papillomavirus vaccine) by GSK, which boosts the immune response for a longer duration.

Access Research Report of Vaccine Adjuvants Market https://www.grandviewresearch.com/industry-analysis/vaccine-adjuvants-market

Vaccine Adjuvants Market Report Highlights

  • The vaccine adjuvants market is segmented based on type into an adjuvant emulsion, pathogen, particulate, combination, and others. The particulate segment held the largest market share in 2024
  • The infectious diseases segment accounted for the largest revenue share of 68.0% in 2024. This large share can be attributed to the gradually growing prevalence of infectious diseases, such as malaria, influenza, hepatitis A, B, & C, and others.
  • The administration segment is categorized into oral, intradermal, intranasal, intramuscular, and others. Due to better immune specificity, the intramuscular segment accounted for the largest revenue share of 33.8% in 2024
  • North America dominated the market and accounted for the largest revenue share of 39.4% in 2024. The factors contributing to the growth of the market in the North American region are a rise in investments for R&D of new therapeutics and an increase in fatal epidemic diseases.

Vaccine Adjuvants Market Report Scope

Report Attribute

Details

Market size value in 2025

USD 3.94 billion

Revenue forecast in 2030

USD 4.86 billion

Growth rate

CAGR of 4.32% from 2025 to 2030

Base year for estimation

2024

Historical data

2018 - 2023

Forecast period

2025 - 2030

List of Key Players of Vaccine Adjuvants Market

  • GlaxoSmithKline plc.
  • Novavax, Inc.
  • Adjuvance Technologies, Inc.
  • SPI Pharma
  • Agenus, Inc.
  • CSL Limited
  • InvivoGen
  • Brenntag Biosector

Access Press Release of Vaccine Adjuvants Market @ https://www.grandviewresearch.com/press-release/global-vaccine-adjuvants-market

About Grand View Research

Grand View Research is an India & U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services.

For More Information: https://www.grandviewresearch.com/horizon

Comments

Popular posts from this blog

U.K. Point Of Sale Software Market To Expand Industry Growth At USD 1.05 Billion By 2028

Gas Detection Equipment Market Anticipated To Expand At A CAGR 9.7% From 2021 To 2028